Show simple item record

dc.contributor.authorO'Mahony, Seamus
dc.date.accessioned2012-02-03T15:07:08Z
dc.date.available2012-02-03T15:07:08Z
dc.date.issued2012-02-03T15:07:08Z
dc.identifier.citationIDrugs. 2005 Jun;8(6):502-7.en_GB
dc.identifier.issn1369-7056 (Print)en_GB
dc.identifier.issn1369-7056 (Linking)en_GB
dc.identifier.pmid15906198en_GB
dc.identifier.urihttp://hdl.handle.net/10147/208909
dc.description.abstractOtsuka is developing a once-daily oral formulation of the phosphodiesterase-4 inhibitor tetomilast for the potential treatment of ulcerative colitis (phase III) and chronic obstructive pulmonary disease (phase II).
dc.language.isoengen_GB
dc.subject.mesh3',5'-Cyclic-AMP Phosphodiesterases/*drug effectsen_GB
dc.subject.meshAnimalsen_GB
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidal/adverse effects/chemicalen_GB
dc.subject.meshsynthesis/contraindications/pharmacology/*therapeutic useen_GB
dc.subject.meshClinical Trials as Topicen_GB
dc.subject.meshClinical Trials, Phase II as Topicen_GB
dc.subject.meshClinical Trials, Phase III as Topicen_GB
dc.subject.meshColitis, Ulcerative/drug therapyen_GB
dc.subject.meshCyclic Nucleotide Phosphodiesterases, Type 4en_GB
dc.subject.meshHumansen_GB
dc.subject.meshPhosphodiesterase Inhibitors/adverse effects/chemicalen_GB
dc.subject.meshsynthesis/contraindications/pharmacology/*therapeutic useen_GB
dc.subject.meshPulmonary Disease, Chronic Obstructive/drug therapyen_GB
dc.subject.meshStructure-Activity Relationshipen_GB
dc.subject.meshThiazoles/adverse effects/chemicalen_GB
dc.subject.meshsynthesis/contraindications/pharmacology/*therapeutic useen_GB
dc.titleTetomilast.en_GB
dc.contributor.departmentCork University Hospital, Wilton, Cork, Ireland. omahonys3@shb.ieen_GB
dc.identifier.journalIDrugs : the investigational drugs journalen_GB
dc.description.provinceMunster
html.description.abstractOtsuka is developing a once-daily oral formulation of the phosphodiesterase-4 inhibitor tetomilast for the potential treatment of ulcerative colitis (phase III) and chronic obstructive pulmonary disease (phase II).


This item appears in the following Collection(s)

Show simple item record